Guardant Health (GH) stock fell after FDA reviewers expressed concerns about its Shield blood test for colorectal cancer ...

Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, unveiled key findings from its groundbreaking eAArly DETECT study during a ...

Higher endoscopist polyp detection rates were significantly associated with fewer negative colonoscopies after positive stool ...

Among patients aged 45 to 49 years undergoing a colonoscopy, adenoma and sessile serrated lesion (SSL) detection rates are comparable to individuals aged 50 to 54 years, according to study findings ...

A study found significant incidence of advanced neoplasia in patients who had a colonoscopy to screen for colorectal cancer ...

vumc.nl Objective: This study aimed to identify the oncogenes at 20q involved in colorectal adenoma to carcinoma progression by measuring the effect of 20q gain on mRNA expression of genes in this ...

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant ...

FAP is a substantially genetic orphan disease for which there are no approved therapeutic options; the current standard of care is surveillance and surgery Phase 3 FAP program is supported by a $17 ...

Low-dose aspirin has a significant association with a decreased risk for gastric adenoma, regardless of a family history of gastric cancer (GC), according to study results published in Digestive and ...

MRI of the pituitary gland revealed a 16 x 27 x 22 mm pituitary adenoma with suprasellar extension, elevation and compression of the optic chiasm, and extension to the right cavernous sinus ...